Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPPHE Hotel Group Limited Regulatory News (PPH)

Share Price Information for PPHE Hotel Group Limited (PPH)

Share Price is delayed by 15 minutes
Get Live Data
2,000.00    -5.00 (-0.25%)
Bid:
1,994.00
Ask:
1,998.00
Spread: 4.00 (0.201%)
Market Cap: £837.17m
PPH Live PriceLast checked at - London Stock Exchange

Intraday PPHE Hotel Group Limited Share Chart

Form 8.5 (EPT/RI) - PPHE Hotel Group Limited

1 Jun 2026 08:50

RNS Number : 4233G
Morgan Stanley & Co. LLC
01 June 2026
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Morgan Stanley & Co. LLC

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

PPHE Hotel Group Limited

(c) Name of the party to the offer with which exempt principal trader is connected:

Fattal Hotel Group

(d) Date dealing undertaken:

29 May 2026

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary NPV

PURCHASES

636

19.8900 GBP

19.8900 GBP

Ordinary NPV

SALES

636

19.8900 GBP

19.8900 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

N/A

N/A

N/A

N/A

N/A

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

N/A

N/A

N/A

N/A

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

N/A

N/A

N/A

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

 

 

Date of disclosure:

01 June 2026

Contact name:

Claire Gordon

Telephone number:

+44 141 245-8893

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERFIFSDRTILIIR
Date   Source Headline
29th Feb 20247:00 amRNSAnnual Results & Publication of Annual Report
28th Feb 20241:41 pmRNSResult of Extraordinary General Meeting
15th Feb 20247:00 amRNSAnnual Results Investor Presentation
8th Feb 20247:00 amRNSAppointment of Co-Chief Executive Officer
7th Feb 20247:00 amRNSProposed Rule 9 Waiver and Notice of EGM
5th Feb 20247:00 amRNSNotice of Annual Results
25th Jan 20247:00 amRNSYear-end Trading Update
23rd Jan 20247:00 amRNSPPHE to open the first Radisson RED in Berlin
19th Jan 20244:19 pmRNSTotal Voting Rights
10th Jan 20247:00 amRNSNotice of Trading Update
8th Jan 20247:00 amRNSAppointment of Advisor
27th Dec 20237:00 amRNSPDMR Notification
27th Dec 20237:00 amRNSHolding(s) in Company
27th Dec 20237:00 amRNSHolding(s) in Company
6th Dec 20237:00 amRNSAppointment of Non-Executive Deputy Chairman
27th Nov 20237:00 amRNSPlanning approval for new hotel in London
9th Nov 20237:00 amRNSMarch 2024 opening of art’otel London Hoxton
26th Oct 20237:00 amRNSPublication of Arena Q3 Interim Financial Report
26th Oct 20237:00 amRNSTrading Update
5th Oct 20237:00 amRNSNotice of Trading Update
27th Sep 20237:00 amRNSCapital returns policy and payment of dividend
12th Sep 20237:00 amRNSOctober opening of art’otel Zagreb
31st Aug 20237:00 amRNSInterim Results
15th Aug 20237:00 amRNSInterim Results Investor Presentation and Q&A
1st Aug 20237:00 amRNSNotice of Interim Results
27th Jul 20237:00 amRNSPublication of Arena Interim Financial Report
29th Jun 20237:00 amRNSPre-Close H1 Trading Update
6th Jun 20237:00 amRNSAnalyst Site Visit to Croatia
23rd May 20234:53 pmRNSResult of Annual General Meeting
15th May 20237:00 amRNSAcceleration of global growth of art’otel brand
11th May 20237:00 amRNSAppointment of Signature Artist at art'otel Hoxton
9th May 20237:00 amRNSRepositioning of art’otel Berlin Mitte
27th Apr 20237:00 amRNSTrading Update
27th Apr 20237:00 amRNSPublication of Arena Q1 Trading Update
25th Apr 20237:00 amRNSSecond hotel under PPHE/Radisson partnership
25th Apr 20237:00 amRNSApproval for European Hospitality Real Estate Fund
18th Apr 202311:22 amRNSNotice of Additional Resolution
11th Apr 20237:00 amRNSNotice of Trading Update
21st Mar 20237:00 amRNSAnnouncement of Posting of AGM Notice
14th Mar 20237:00 amRNSEuropean Hospitality Real Estate Fund
8th Mar 20237:00 amRNSTransaction in own securities
2nd Mar 20235:30 pmRNSPDMR purchase of shares in the Company
2nd Mar 20234:56 pmRNSGrant and exercise of EVP Annual Bonus Plan awards
2nd Mar 20237:00 amRNSAnnual Results & Publication of Annual Report
2nd Mar 20237:00 amRNSEuropean Hospitality Real Estate Fund
1st Mar 20237:00 amRNSTransaction in own securities
28th Feb 20233:07 pmRNSPublication of Arena Hospitality Annual Report
28th Feb 20237:00 amRNSTransaction in own securities
27th Feb 20237:00 amRNSTransaction in own securities
24th Feb 20237:00 amRNSTransaction in own securities

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.